Asarfi Hospital Limited

BSE: ASARFI · Hospital · sector

₹170.10BSE close 2026-10-26

Key numbers

Market cap₹335 cr

Price₹170.10

52w high / low₹257 / ₹135

P/E20.1xSector median 42.5x

P/B4.3xSector median 4.9x

Book value₹39.6

Dividend yield–Sector median 0.17%

ROE23.9%Sector median 12.1%

ROCE33.9%Sector median 13.8%

OPM20.3%Sector median 20.3%

Debt / equity–Sector median 0.24x

EV/EBITDA9.1xSector median 23.6x

Interest cover6.2x

Current ratio1.45x

Sales growth 3y–Sector median +14.1%

Profit growth 3y–Sector median +14.7%

PEG–

Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 6.2x in the last 12 months.
Other income was 16% of net profit in the last 12 months.
No dividend in the last 3 financial years.
Price ₹170.10 on 2026-10-26: -33.8% from the 52-week high, +26.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹249.45 · low ₹54.48

Quarterly results

₹ cr	Mar 2025	Sep 2025	Mar 2026
Revenue	67	81	92
EBITDA	12	16	19
OPM %	18.0%	19.7%	20.2%
Other income	6	2	1
Net profit	6	7	9
EPS (₹)	3.19	2.19	4.75

Consolidated figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY24	FY25	FY26	TTM
Revenue	84	121	174	174
EBITDA	16	24	35	35
Net profit	4	11	17	17
EPS (₹)	2.33	5.37	8.47	8.47
Revenue growth		+42.9%	+43.9%	–
Profit growth		+151.3%	+57.5%	–
Dividend / share (₹)	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	+81.5% (2y)	+23.1%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	61	78
Cash & equivalents	1	13
Total assets	164	193
Fixed assets	102	108
Investments	0	0
Inventory	2	3

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-4	18
Cash from investing	-7	-18
Cash from financing	13	5
Capex	12	18
Free cash flow	-16	0

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	17.3%	21.4%
ROCE %	30.0%	33.9%
Inventory days	30	30
Working capital days	53	47

Peers in Hospital

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
APOLLOHOSP	₹1,12,797 cr	54.0x	11.9x	23.6%	21.8%	15.1%	+14.9%	0.26%
MAXHEALTH	₹81,266 cr	55.7x	7.6x	14.5%	13.8%	26.1%	+22.4%	0.18%
MANIPALHOS	₹73,581 cr	–	–	–	–	–	–	–
FORTIS	₹55,467 cr	52.9x	5.6x	11.1%	13.2%	22.2%	+13.2%	0.14%
NH	₹33,971 cr	41.4x	7.5x	20.0%	13.7%	18.7%	+20.4%	0.26%
ASTERDM	₹33,523 cr	104.7x	7.3x	8.0%	12.8%	16.7%	-27.0%	0.16%
MEDANTA	₹32,575 cr	58.5x	8.2x	15.1%	15.8%	20.5%	+17.9%	0.04%
KIMS	₹28,123 cr	131.3x	12.5x	9.3%	9.6%	19.5%	+21.1%	0.74%
AGARWALEYE	₹15,065 cr	101.3x	7.4x	7.6%	16.5%	27.8%	–	0.01%
ASARFI	₹335 cr	20.1x	4.3x	23.9%	33.9%	20.3%	–	–

All 32 companies in Hospital →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Hospital
Sub-industry	Hospital
Symbol	ASARFI
BSE code	543943
ISIN	INE0DN001027
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.